Roche partners for translational research

Tuesday, June 7, 2011 03:24 PM

The University of Geneva (UNIGE), Geneva University Hospitals (HUG) and the Swiss Institute of Bioinformatics (SIB) have formed a strategic collaboration with Roche in translational medical research. The initial focus will be on basic research, bioinformatics and biomarker development in cardiology, hematology, pathology and applied human toxicology.

"We consider Geneva as one of the few centers that combines the expertise of world-class specialists in the field of proteomics and bioinformatics, with a strong translational set-up between labs and the clinic," said Jacky Vonderscher, global head of translational research sciences at Roche. "This close link between diverse disciplines is absolutely key to better understand the diseases at the molecular level and ultimately to discover new diagnostic and therapeutic interventions."

Translational medical research translates basic scientific research into medical practice with the ultimate objective to deliver personalized healthcare to patients. This collaboration will focus on promising fields such as biomarkers, applied human toxicology and bioinformatics, with a goal to develop better medical diagnostics and treatment choices tailored to patients. Roche has established such collaborations with distinguished universities in the U.S., Asia and Europe. "Innovation is at the core of Roche R&D to deliver better medicines to patients and we want to partner with excellent academic universities to progress translational research from the lab to patients," said Azhar Khan, Head of Roche Academic Alliances.

"This agreement witnesses the high level of competences of Geneva's scientists and clinicians," said Denis Hochstrasser, professor at the medical and sciences faculties and initiator of the partnership.

Projects will be selected jointly based on areas of mutual interest in line with scientific and ethical guidelines and rules of the collaborating institutions.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private á¼€nancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs